EMD Serono , a pharmaceutical company that focuses on neurodegenerative diseases including multiple sclerosis, has recently announced that it will open a site in Cambridge. The laboratory space in Cambridge will accommodate its drug discovery activities and will secure necessary space for additional scientists as a result of accelerated employee growth. The Cambridge satellite laboratory will be approximately 18,000 SF in size and will be occupied by an estimate of 50 scientists.
(Click to Expand)
There are no comments
Please login to post comments